


Clinical Dilemmas in Inflammatory Bowel Disease
Irving, P.
1ª Edición Junio 2006
Inglés
Tapa blanda
264 pags
1000 gr
19 x 25 x 2 cm
ISBN 9781405133777
Editorial WILEY
Recíbelo en un plazo De 7 a 10 días
DESCRIPTION
Evidence-based guidance to answer more than 60 controversial clinical questions on inflammatory bowel disease
Clinical Dilemmas in Inflammatory Bowel Disease is a practical handbook providing quick but detailed answers to the questions and challenges that you are faced with daily in the clinical setting.
Each short chapter addresses a different topic and provides evidence-based guidance on subjects ranging from optimising current management through to special management problems and novel treatments.
This book is suitable for all medical professionals involved in the care of patients with IBD: established and trainee gastroenterologists, colorectal surgeons, pathologists, radiologists, specialist nurses, pharmacists, dieticians and counsellors
TABLE OF CONTENTS
- Part 1 Investigating IBD in the 21st Century
1 Capsule endoscopy: do we need it?
2 Pathology reports - pitfalls for the unwary
3 Non-invasive diagnosis and assessment
4 What is the best way to image perianal Crohn's disease?
5 Surveillance colonoscopy in UC: alternatives and ways to improve outcome
6 Abnormal liver tests - what should we do about them? - Part 2 Medical Treatment: Making the Most of What We've Got
5-ASA drugs
7 Is monitoring necessary?
8 Do they have a role in Crohn's disease?
Steroids
9 Steroids in Crohn's: are they obsolete?
Antibiotics for Crohn's disease
10 Antibiotics: which, when and for how long?
11 Mycobacterium avium paratuberculosis in Crohn's disease: player or spectator?
Immunomodulators
12 TPMT testing: is it essential?
13 6-Mercaptopurine or azathioprine?
14 Thiopurines: how long should we use them for?
15 Making the most of methotrexate
16 Cyclosporine: balancing risk and benefit
Infliximab
17 Contraindications - absolute or relative?
18 How can we prevent tuberculosis?
19 Dealing with infusion reactions
20 Use in ulcerative colitis
21 Infliximab and surgery: health or hazard?
Nutritional therapy for Crohn's disease
22 Nutritional therapy for Crohn's disease: is it for adults? - Part 3 Medical Treatment: What's Round the Corner?
23 Trials and tribulations - interpreting clinical trials in IBD
24 Genetics - clinical and therapeutic applications
25 Probiotics - separating science from snakeoil
26 Worms
27 Smoking and nicotine - poison for Crohn's, potion for colitis?
28 Heparin
29 Leukocytapheresis: filtering out the facts
30 Appendectomy for ulcerative colitis - a therapeutic option?
31 Biologic treatments in IBD
32 Stem cell transplantation for IBD
33 Complementary and alternative therapy - the way forward or a step back? - Part 4 Common Clinical Challenges: Beyond the Text Book
34 Functional problems
35 Psychological stress: something to worry about?
36 Drugs to avoid
37 NSAIDs and COX-2 selective agents: cause or cure of pain in IBD?
38 Iron replacement - is it safe and effective?
39 Hepatitis B and C viruses - how do they affect management of IBD?
40 Pregnancy: what drugs can we use?
41 How to prevent growth failure in children
42 Predicting outcomes in severe UC
43 Refractory proctitis
44 CMV co-infection - does it matter?
45 Treatment of oral Crohn's disease
46 Pathophysiologic approach to treatment of diarrhea in Crohn's disease
47 Short bowel
48 Management of internal fistulae
49 What is indeterminate colitis?
50 Pouches for indeterminate colitis?
51 Colitis-associated cancer: what's the risk to your patients?
52 What to do with dysplasia, DALMs, and adenomas - Part 5 Managing IBD Outside the Gut
53 Pyoderma gangrenosum
54 Arthritides - helping the joints without harming the gut
55 Prevention and treatment of osteoporosis
56 Sclerosing cholangitis - what to do?
57 Thromboembolic disease: an under-recognized complication?
58 Pulmonary manifestations: rare but real - Part 6 Are You Sure it's IBD?
59 Intestinal infections: mimics and precipitants of relapse
60 Microscopic colitis
61 Diverticular colitis - Part 7 The IBD Service: Time for a Rethink?
62 Outpatient services - do doctors still have a role?
63 Shared care: tactical team selection
64 Databases - are they worth the bother? - Index
ABOUT THE AUTHOR
Peter Irving, Centre for Gastroenterology, Institute of Cell and Molecular Science, Barts and the London, Queen Mary School of Medicine and Dentistry, London, UK.
David Rampton, Professor of Clinical Gastroenterology at the Centre for Gastroenterology, Institute of Cell and Molecular Science, Barts and the London, Queen Mary School of Medicine and Dentistry, London, UK.
Fergus Shanahan, Professor and Chair of the Department of Medicine, National University of Ireland Cork, Cork University Hospital, Cork, Eire.
Fax91 448 21 88
DirC / Raimundo Lulio, 1, 28010 Madrid, España.
Mailpedidosweb@axon.esPrivacidadCondiciones de ventaQuiénes SomosAvisoContacto© 2021 Axón Librería S.L.
v1.53.0